CMN Intelligence

The world’s most comprehensive intelligence platform for CRISPR-Genomic Medicine and gene-editing clinical development.

Providing market intelligence, data infrastructure, analytics, and reporting services for the global gene-editing sector.

CMN Trials Global Report (>250 trials)

First Edition 2026: Available February 2026. Secure the first edition of the CMN Trials Global Report here.

Download your first sample report.

The CMN Trials Global Report 2026 includes comprehensive and up-to-date clinical trial data (figures only) from the CMN Trial Database 2.0, covering approximately 300 clinical trials worldwide.The first global edition of the report will be available in February 2026. This report and any figures or extracts derived from it are intended for internal use only and may not be shared outside your company or organisation.All content and figures are copyright protected.

This report includes among others detailed insights on:

Disease/Indication
Trial Locations (by country)
Phase
Editing Approach
Type of Edit
Editing Modality
Delivery Vehicle for Gene-Editing Reagents
Delivery Vehicle for Repair Template
Delivery Format for Gene-Editing Reagents
Delivery Format for Repair Template
Route of Administration
...

Request further details regarding license availability for 2026.

Meet the global CRISPR Medicine community in Copenhagen, April 13-16, at CRISPRMED26.